| Product Identity | Clearly identified as calcium glycinate or calcium bisglycinate chelate, with the chemical form and applicable specification stated consistently. | Different calcium salts have different elemental-calcium levels, solubility, sensory properties, and formulation behavior. | Product specification, technical data sheet, certificate of analysis, and an identity test such as FTIR or another validated method. | Essential |
| Elemental Calcium Content | Elemental calcium should be declared as a percentage or amount per serving. Calcium bisglycinate products commonly contain approximately 18%–21% elemental calcium, but the exact value depends on the material specification. | The elemental-calcium level determines dosage calculations, label claims, capsule size, and product cost. | Recent batch COA with assay results, analytical method, test date, and acceptance range. | Essential |
| Chelation and Manufacturing Description | The supplier should explain whether the product is manufactured as a defined amino-acid chelate and should provide a consistent manufacturing description without unsupported “high absorption” claims. | Clear technical information helps distinguish a defined chelated ingredient from a simple blend of calcium and an amino acid. | Manufacturing overview, process flow summary, identity data, and technical declaration of the material form. | High Priority |
| Assay and Analytical Control | Calcium assay should be tested using a suitable validated method, commonly ICP-OES, ICP-MS, or another method appropriate to the specification. | Accurate assay results support dose uniformity and regulatory compliance. | Method reference, laboratory qualification information, raw or summarized test data, and batch-specific COA. | Essential |
| Purity and Contaminants | Limits should be defined for lead, arsenic, cadmium, mercury, and other contaminants according to the destination market and applicable food or supplement regulations. | Mineral ingredients can introduce elemental impurities through raw materials, water, processing equipment, or the environment. | Heavy-metal test report, risk assessment, specification limits, and periodic third-party laboratory results. | Essential |
| Microbiological Quality | Specifications should cover total aerobic microbial count, yeast and mold, and relevant pathogens where required by the intended application. | Microbiological control is important for powders used in dietary supplements, food, and nutrition products. | Batch microbiology report, sampling plan, environmental monitoring summary, and pathogen-control procedure. | Essential |
| Physical Characteristics | Powder appearance, color, odor, particle-size profile, bulk density, flowability, and solubility or dispersibility should be specified when relevant. | Physical properties affect blending, encapsulation, tablet compression, suspension stability, and consumer experience. | Physical specification, particle-size data, bulk-density results, and application or compatibility samples. | High Priority |
| Moisture and Stability | Moisture content or loss on drying should have a defined limit, with packaging designed to protect the powder from humidity. | Excess moisture can cause caking, poor flow, degradation of associated ingredients, and inconsistent dosing. | Moisture test results, stability data, recommended storage conditions, and shelf-life statement. | High Priority |
| Regulatory and Quality Certifications | Prefer documented compliance with a recognized quality system, such as GMP or an equivalent system appropriate to the product category and manufacturing location. | A functioning quality system supports controlled production, traceability, deviation handling, and corrective actions. | Current certification, audit report or summary, quality manual overview, and corrective-action records when applicable. | Essential |
| Traceability | Every shipment should have a unique lot number linked to raw-material records, production records, testing results, and packaging information. | Traceability enables effective investigations, targeted withdrawals, and verification of batch consistency. | Lot-number format, traceability procedure, sample batch record, and recall procedure. | Essential |
| Allergen and Dietary Status | The supplier should disclose relevant allergen risks, animal-derived materials, genetically modified inputs where applicable, irradiation status, and other dietary claims required by the market. | These factors may determine whether the ingredient is suitable for vegetarian, vegan, allergen-controlled, religious, or clean-label products. | Allergen statement, origin declaration, processing-aid statement, and applicable dietary-status certificates. | High Priority |
| Packaging and Storage | Packaging should provide a suitable moisture and contamination barrier. Storage instructions should normally include a cool, dry environment and protection from direct sunlight. | Appropriate packaging preserves powder quality during transport and storage. | Packaging specification, transport conditions, storage instructions, and packaging-integrity controls. | High Priority |
| Supply Capacity and Lead Time | The supplier should provide realistic minimum order quantities, standard lead times, production capacity, and a continuity plan for raw materials and packaging. | Supply interruptions can delay product launches and create formulation or labeling changes. | Quotation, capacity statement, forecast procedure, lead-time history, and business-continuity plan. | High Priority |
| Sample and Pilot Validation | Samples should be tested in the intended formulation before commercial approval, including blending, compression or encapsulation, sensory behavior, and stability where applicable. | Laboratory specifications alone cannot predict every processing or formulation outcome. | Representative sample, sample COA, application protocol, pilot-batch results, and retained-sample policy. | Essential |
| Change-Control Procedure | The supplier should notify customers before significant changes to raw materials, manufacturing location, process, analytical method, specification, or packaging. | Unannounced changes may affect product performance, regulatory filings, and label accuracy. | Change-control policy, notification period, requalification procedure, and approved-supplier agreement. | High Priority |
| Commercial Transparency | Pricing should be evaluated together with elemental-calcium content, testing, packaging, shipping terms, minimum order quantity, and payment conditions. | The lowest price per kilogram may not represent the lowest cost per effective calcium dose or finished product unit. | Complete quotation, cost-per-dose calculation, Incoterms, payment terms, and validity period. | High Priority |